Ipratropium inhalation

Generic name: Ipratropium Inhalation
Drug class: Anticholinergic bronchodilators

Usage of Ipratropium inhalation

Ipratropium is a bronchodilator that is used to to prevent bronchospasm in people with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Ipratropium inhalation may also be used for purposes not listed in this medication guide.

Ipratropium inhalation side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

You may need to use a different bronchodilator medication if you have an allergic reaction to ipratropium inhalation.

Ipratropium inhalation may cause serious side effects. Call your doctor at once if you have:

wheezing, choking, or other breathing problems after using ipratropium inhalation;

little or no urination;

blurred vision, tunnel vision, eye pain, or seeing halos around lights; or

worsened breathing problems.

Common side effects of ipratropium inhalation may include:

cold symptoms such as stuffy nose, sneezing, sore throat;

cough with mucus, chest tightness, trouble breathing; or

tiredness, or headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Ipratropium inhalation

You should not use ipratropium inhalation if you are allergic to ipratropium or atropine.

Tell your doctor if you have ever had:

glaucoma;

an enlarged prostate; or

bladder obstruction or other urination problems.

Tell your doctor if you are pregnant or breastfeeding.

Ipratropium inhalation aerosol is not approved for use by anyone younger than 18 years old. Ipratropium inhalation solution is not approved for use by anyone younger than 12 years old.

Relate drugs

How to use Ipratropium inhalation

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

Inhalation aerosol: 2 inhalations (34 mcg) orally four times a day, or as needed up to 12 inhalations in 24 hoursNebulizer inhalation solution: 500 mcg three or four times a day by oral nebulization, with doses 6 to 8 hours apartUse:-Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

Usual Pediatric Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

Nebulizer inhalation solution:Less than 12 years: Safety has not been established.12 years or older: 500 mcg three or four times a day by oral nebulization, with doses 6 to 8 hours apartUse:-Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

Warnings

Do not get this medicine in your eyes, especially if you have glaucoma.

Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.

What other drugs will affect Ipratropium inhalation

Tell your doctor about all your other medicines, especially:

medicine to treat depression, anxiety, mood disorders, or mental illness;

cold or allergy medicine (Benadryl and others);

medicine to treat Parkinson's disease;

medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

medicine to treat overactive bladder; or

another bronchodilator medication.

This list is not complete. Other drugs may affect ipratropium, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.